XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

Researchers evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA) in type ...

High intake of ultra-processed foods is linked to adverse metabolic health and microstructural brain changes in regions that ...

The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood ...

Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the ...

Over the years, there have been significant changes to the dyslipidemia medication management guidelines, alongside ...

If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

Hanmi Pharmaceutical announced that it has completed the launch of Aditams in Mexico under the export agreement signed in ...

Patients at risk for heart disease experienced significant reductions in apolipoprotein B and LDL cholesterol levels on ...

High levels of this cholesterol are a key risk factor in strokes and heart attacks. Dyslipidemia, where patients may have high cholesterol levels, remains unsolved, with the standard of care being ...

China: A retrospective study published in Frontiers in Endocrinology suggests that effective management of dyslipidemia may help preserve kidney function in individuals with diabetes. The study found ...

AHA 2024 New Pill Successfully Lowers Lp(a) Levels Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk and for which no ...